JPS51142545A - Antibiotic agent - Google Patents

Antibiotic agent

Info

Publication number
JPS51142545A
JPS51142545A JP51059224A JP5922476A JPS51142545A JP S51142545 A JPS51142545 A JP S51142545A JP 51059224 A JP51059224 A JP 51059224A JP 5922476 A JP5922476 A JP 5922476A JP S51142545 A JPS51142545 A JP S51142545A
Authority
JP
Japan
Prior art keywords
antibiotic agent
antibiotic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP51059224A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5410618B2 (US20100056889A1-20100304-C00004.png
Inventor
Piitaa Guranatetsuku Arufuonsu
Aasaa Kapuran Maarei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS51142545A publication Critical patent/JPS51142545A/ja
Publication of JPS5410618B2 publication Critical patent/JPS5410618B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP51059224A 1975-05-23 1976-05-24 Antibiotic agent Granted JPS51142545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/580,268 US4001409A (en) 1975-05-23 1975-05-23 Injectable formulations of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid

Publications (2)

Publication Number Publication Date
JPS51142545A true JPS51142545A (en) 1976-12-08
JPS5410618B2 JPS5410618B2 (US20100056889A1-20100304-C00004.png) 1979-05-08

Family

ID=24320409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51059224A Granted JPS51142545A (en) 1975-05-23 1976-05-24 Antibiotic agent

Country Status (4)

Country Link
US (1) US4001409A (US20100056889A1-20100304-C00004.png)
JP (1) JPS51142545A (US20100056889A1-20100304-C00004.png)
DE (1) DE2622985C3 (US20100056889A1-20100304-C00004.png)
FR (1) FR2311550A2 (US20100056889A1-20100304-C00004.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100512098B1 (ko) * 2001-12-10 2005-09-05 (주)마이크로바이오텍 레불린산 및 그의 유도체를 함유한 항생제, 화장품 및 식품

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867380A (en) * 1971-02-18 1975-02-18 Smithkline Corp 3-Heterocyclic thiomethylcephalosporins
US3855213A (en) * 1971-02-18 1974-12-17 Smith Kline French Lab 3-heterocyclic thiomethyl-cephalosporins
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method

Also Published As

Publication number Publication date
JPS5410618B2 (US20100056889A1-20100304-C00004.png) 1979-05-08
FR2311550A2 (fr) 1976-12-17
US4001409A (en) 1977-01-04
DE2622985C3 (de) 1978-11-02
DE2622985A1 (de) 1976-11-25
FR2311550B2 (US20100056889A1-20100304-C00004.png) 1978-11-17
DE2622985B2 (de) 1978-03-09

Similar Documents

Publication Publication Date Title
JPS51144723A (en) Antiitumor agent
PH18612A (en) New antibiotic substance
JPS52142091A (en) Antibiotic agent
JPS51122091A (en) Antiibacterial agent
JPS5214798A (en) Antiibacterial agent
JPS51133266A (en) Antibacterial agent
JPS5248686A (en) Antibiotics
JPS525787A (en) Antiibacterial agent
JPS5253891A (en) Antibiotics
JPS5261231A (en) Antiitumor agent
JPS51112527A (en) Antiivirus agent
ZA761370B (en) Streptomycetal antibiotic
JPS51123812A (en) Chrystalltne antibiotic
JPS536426A (en) Antibiotic agent
JPS5312425A (en) Antibiotic agent
JPS5251390A (en) Antibiotic substance
JPS5268195A (en) Antiibacterial agent
ZA766967B (en) Smell-removing agent
JPS5265291A (en) Antibiotic compound
JPS527420A (en) Antimelancholia agent
JPS51112596A (en) Antibiotic
JPS5251391A (en) Antibiotic substance
JPS51112447A (en) Antiiscale agent
AU1737176A (en) Antibiotic
AU1190076A (en) Antibiotic